Zeng FX - Search Results

1

Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study.

Zhou CH, Yang F, Jiang WJ, Zhang YC, Yang HY, Zeng L, Liu L, Xiong Y, Zeng FX, Wang Z, Yang N. Zhou CH, et al. Among authors: zeng fx. Front Pharmacol. 2021 Nov 17;12:727102. doi: 10.3389/fphar.2021.727102. eCollection 2021. Front Pharmacol. 2021. PMID: 34867332 Free PMC article.

2

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer.

Chen G, Chen Q, Zeng F, Zeng L, Yang H, Xiong Y, Zhou C, Liu L, Jiang W, Yang N, Zhang Y. Chen G, et al. Oncotarget. 2017 Dec 14;8(70):115270-115279. doi: 10.18632/oncotarget.23252. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383158 Free PMC article.

3

Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer.

Wu F, Lin X, Yang Z, Sun Z, Zeng F, Heng J, Qu J, Zeng L, Yang N, Zhang Y. Wu F, et al. Clin Lung Cancer. 2018 Nov;19(6):e913-e918. doi: 10.1016/j.cllc.2018.08.006. Epub 2018 Aug 23. Clin Lung Cancer. 2018. PMID: 30197265 Clinical Trial.

4

EGFR exon 21 L858R as an acquired resistance mechanism to nivolumab in a lung cancer patient originally driver gene-negative.

Xia C, Zeng F, Zhang Y. Xia C, et al. Thorac Cancer. 2019 May;10(5):1256-1259. doi: 10.1111/1759-7714.13023. Epub 2019 Feb 27. Thorac Cancer. 2019. PMID: 30810279 Free PMC article.

5

Efficacy of Joungal in preventing febrile neutropenia induced by platinum-based doublet chemotherapy in lung cancer.

Zeng F, Li T, Xia C, Chen G, Sun Z, Guan R, Lizaso A, Mao X, Li K, Zhang Y. Zeng F, et al. Ann Palliat Med. 2020 Jul;9(4):1688-1695. doi: 10.21037/apm-19-531. Epub 2020 Jun 23. Ann Palliat Med. 2020. PMID: 32648449 Free article.

6

PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study.

Huang Z, Zhou C, Xiong Y, Yang F, Zeng F, Jiang W, Zhang Y, Yang H, Liu L, Zeng L, Yang N, Wang Z. Huang Z, et al. Front Oncol. 2022 Nov 9;12:909721. doi: 10.3389/fonc.2022.909721. eCollection 2022. Front Oncol. 2022. PMID: 36439441 Free PMC article.

7

Copy number variations mediate major pathological response to induction chemo-immunotherapy in unresectable stage IIIA-IIIB lung cancer.

Zeng L, Zhou Y, Zhang X, Xu Q, Zhou C, Zeng F, Jiang W, Wang Z, Deng L, Yang H, Liu L, Xiong Y, Zhang B, Yang N, Zhang Y. Zeng L, et al. Lung Cancer. 2023 Apr;178:134-142. doi: 10.1016/j.lungcan.2023.02.017. Epub 2023 Feb 24. Lung Cancer. 2023. PMID: 36858002

8

Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer.

Liu C, Zeng L, Deng C, Jiang W, Wang Y, Zhou Y, Liu L, Wang S, Zhou C, Qiu Z, Zeng F, Wu F, Weng J, Liu X, Yang N, Ma F. Liu C, et al. Front Immunol. 2023 Jun 7;14:1175960. doi: 10.3389/fimmu.2023.1175960. eCollection 2023. Front Immunol. 2023. PMID: 37350968 Free PMC article.

9

Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics.

Zhang Y, Zeng F, Peng S, Chen Y, Jiang W, Wang Z, Deng L, Huang Z, Qin H, Yan H, Zhang X, Zhang L, Yang N, Gong Q, Zeng L, Zhang Y. Zhang Y, et al. Expert Rev Respir Med. 2023 Jul-Dec;17(9):743-751. doi: 10.1080/17476348.2023.2265810. Epub 2023 Oct 27. Expert Rev Respir Med. 2023. PMID: 37776047

10

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer.

Wang XS, Bai YF, Verma V, Yu RL, Tian W, Ao R, Deng Y, Zhu XQ, Liu H, Pan HX, Yang L, Bai HS, Luo X, Guo Y, Zhou MX, Sun YM, Zhang ZC, Li SM, Cheng X, Tan BX, Han LF, Liu YY, Zhang K, Zeng FX, Jia L, Hao XB, Wang YY, Feng G, Xie K, Lu Y, Zeng M. Wang XS, et al. Among authors: zeng fx. J Natl Cancer Inst. 2023 Jun 8;115(6):742-748. doi: 10.1093/jnci/djac015. J Natl Cancer Inst. 2023. PMID: 35094066 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page